Home › Funds › Vivo Capital, LLC › UNCY

Vivo Capital, LLC position in UNCY

UNICYCIVE THERAPEUTICS INC · Health Care

Vivo Capital, LLC reported holding 550,000 shares of UNCY (UNICYCIVE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.24% of its reported portfolio and ranking #42 among its reported holdings. Vivo Capital, LLC has disclosed UNCY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)550.00K sh
Reported value held$2.58M
Portfolio Weight0.24%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's UNCY position evolved

Vivo Capital, LLC first disclosed a stake in UNCY in Q3 2023 at 3,470,152 shares (US$3.0M). The position peaked in Q1 2026 at 1,789,916 shares, worth US$11.8M. Across 12 filings, Vivo Capital, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 550,000 shares valued at US$2.6M — a reduction of -1,239,916 shares quarter over quarter.. Notable position changes include a 123% increase in Q4 2024 (shares fell 28% over the following quarter), a 90% trim in Q2 2025 (shares fell 9% over the following quarter), a 69% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.47M $2.98M New
Q4 2023 3.47M $3.01M Hold
Q1 2024 3.47M $4.79M Hold
Q2 2024 3.47M $1.74M Hold
Q3 2024 4.47M $1.82M Add
Q4 2024 9.97M $7.92M Add
Q1 2025 11.37M $6.54M Add
Q2 2025 1.14M $5.42M Reduce
Q3 2025 1.79M $7.80M Add
Q4 2025 1.79M $10.33M Hold
Q1 2026 1.79M $11.78M Hold
Q2 2026 550.00K $2.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UNCY and 13F data

UNCY (UNICYCIVE THERAPEUTICS INC) is a Health Care company. 68 other funds we track also report a position in UNCY — the largest reported positions include Octagon Capital Advisors LP (US$4.7M), Dauntless Investment Group, LLC (US$1.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UNCY

All UNCY fund holders →

FAQ

How long has Vivo Capital, LLC held UNCY?

Vivo Capital, LLC has disclosed UNCY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Vivo Capital, LLC's current position in UNCY?

As of Q2 2026, Vivo Capital, LLC holds 550.00K shares of UNCY (UNICYCIVE THERAPEUTICS INC), valued at $2.58M, representing 0.24% of its reported portfolio and ranking #42.

Has Vivo Capital, LLC been buying or selling UNCY?

In the latest 13F filing (Q2 2026), Vivo Capital, LLC reduced its position in UNCY. The position peaked in Q1 2026 at 1.79M shares.

Which other funds hold UNCY?

Other major institutional holders of UNCY include Octagon Capital Advisors LP, Dauntless Investment Group, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.